|

Heart Disease Clinical Trials in Maine

20 recruiting studies across 5 cities

All Trials in Maine

Phase
Trial Phase Location
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Augusta
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Bangor
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Bangor
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Bangor
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Bangor
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3Bangor
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Biddeford
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3Portland
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Portland
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting—Portland
Cardiogenic Shock Working Group Registry—Portland
Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)—Portland
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Portland
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Portland
Studies of Neuregulin/ERBB Signaling in Human Heart—Portland
Transfusion Requirements in Younger Patients Undergoing Cardiac SurgeryN/APortland
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/APortland
EFS of the DUO System for Tricuspid RegurgitationN/AScarborough
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Scarborough
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3Scarborough

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.